Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2011 (2011), Article ID 124940, 3 pages
http://dx.doi.org/10.1155/2011/124940
Case Report

Leukocytoclastic Vasculitis in a Patient with Type 1 Cryoglobulinemia

1Division of Rheumatology, Department of Medicine, University of California, Irvine, Orange, CA 92868, USA
2Veterans Administration Healthcare System, Long Beach, CA 90822, USA

Received 9 July 2011; Accepted 3 August 2011

Academic Editors: J. V. Dunne, M. Salazar-Paramo, and A. Zoli

Copyright © 2011 Paul Y. Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. Pol-Rodriguez, S. Crane, D. L. Feinberg, E. J. Glusac, and J. L. Bolognia, “Retiform purpura,” Archives of Dermatology, vol. 139, no. 6, pp. 803–808, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. J. A. Carlson, “The histological assessment of cutaneous vasculitis,” Histopathology, vol. 56, no. 1, pp. 3–23, 2010. View at Publisher · View at Google Scholar · View at PubMed
  3. A. T. Vila, M. A. Barnadas, J. Ballarin et al., “Cutaneous ulcers with type I cryoglobulinemia treated with plasmapheresis,” European Journal of Dermatology, vol. 14, no. 3, pp. 186–189, 2004. View at Google Scholar
  4. S. J. Cohen, M. R. Pittelkow, and W. P. D. Su, “Cutaneous manifestations of cryoglobulinemia: clinical and histopathologic study of seventy-two patients,” Journal of the American Academy of Dermatology, vol. 25, no. 1, pp. 21–27, 1991. View at Google Scholar
  5. K. S. Resnik, “Intravascular eosinophilic deposits-when common knowledge is insufficient to render a diagnosis,” American Journal of Dermatopathology, vol. 31, no. 3, pp. 211–217, 2009. View at Publisher · View at Google Scholar · View at PubMed
  6. S. De Vita, L. Quartuccio, and M. Fabris, “Rituximab in mixed cryoglobulinemia: increased experience and perspectives,” Digestive and Liver Disease, vol. 39, supplement 1, pp. S122–S128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Zaja, S. De Vita, C. Mazzaro et al., “Efficacy and safety of rituximab in type II mixed cryoglobulinemia,” Blood, vol. 101, no. 10, pp. 3827–3834, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. E. Rosenthal, A. Pesce, J. M. Karsenti, M. A. Allieri-Rosenthal, and J. P. Cassuto, “Polyneuropathy and vasculitis associated with IgG type I cryoglobulinemia can be treated effectively withthe anti-CD20 monoclonal antibody (rituximab),” Blood, vol. 98, article 292, 2001. View at Google Scholar
  9. H. Nehme-Schuster, A. S. Korganow, J. L. Pasquali, and T. Martin, “Rituximab inefficiency during type I cryoglobulinaemia,” Rheumatology, vol. 44, no. 3, pp. 410–411, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus